XML 12 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenue:        
Revenue $ 150,719 $ 118,262 $ 434,769 $ 344,292
Cost of sales 47,990 38,215 132,095 129,279
Gross profit 102,729 80,047 302,674 215,013
Operating expenses:        
Research and development 20,357 20,000 57,474 47,831
Sales, general and administrative 109,200 91,411 335,658 269,960
Litigation-related expenses 2,093 2,715 8,611 12,815
Amortization of acquired intangible assets 3,848 3,873 11,538 10,461
Transaction-related expenses   278 (117) 2,178
Restructuring expenses 934 129 1,861 333
Total operating expenses 136,432 118,406 415,025 343,578
Operating loss (33,703) (38,359) (112,351) (128,565)
Interest expense and other expense, net:        
Interest expense, net (6,572) (4,459) (17,728) (12,225)
Other income, net 623 47 897 3,077
Total other expense, net (5,949) (4,412) (16,831) (9,148)
Net loss before taxes (39,652) (42,771) (129,182) (137,713)
Income tax benefit (36) (117) (391) (153)
Net loss $ (39,616) $ (42,654) $ (128,791) $ (137,560)
Net loss per share, basic $ (0.28) $ (0.35) $ (0.9) $ (1.18)
Net loss per share, diluted $ (0.28) $ (0.35) $ (0.9) $ (1.18)
Weighted average shares outstanding, basic 143,492 122,468 142,400 117,026
Weighted average shares outstanding, diluted 143,492 122,468 142,400 117,026
Products and Services        
Revenue:        
Revenue $ 150,719 $ 118,262 $ 434,769 $ 344,292